Bicycle Therapeutics PLC at TD Cowen Fall Oncology Innovation Summit (Virtual) Transcript
Good morning, everyone. I want to welcome you to TD Cowen 7th Annual Fall Oncology Innovation Summit. We are here with Alethia Young, the CFO of Bicycle Therapeutics. So thank you for joining us today, Alethia.
I want to remind folks real quick out there that you can send any burning questions that you have to me via e-mail at [email protected] and I will be sure to incorporate it.
So to start, before diving into more specific questions on your clinical programs and pipeline, Alethia, can you provide an overview of Bicycle and a general update to kick things off?
Yes, sure. Thanks, Tara, and thanks to Cowen for having us today; we're obviously, really excited to be here. To talk a little bit of a Bicycle Therapeutics -- it's highest level on the technology -- we're a clinical-stage company with pioneering new differentiated technology effectively a novel therapeutic modality based on Nobel Prize-winning science from Sir Greg Winter that won Nobel Prize for phage display in 2018. And so, what
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
